Kunming Longjin Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2025: 39.53%

Kunming Longjin Pharmaceutical Co Ltd (002750) has an Asset Resilience Ratio of 39.53% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Kunming Longjin Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥219.44 Million

≈ $32.11 Million USD Cash + Short-term Investments

Total Assets

CN¥555.15 Million

≈ $81.24 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Kunming Longjin Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 002750 total asset value.

Liquid Assets Composition Over Time

This chart breaks down Kunming Longjin Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 002750 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥219.44 Million	39.53%
Total Liquid Assets	CN¥219.44 Million	39.53%

Asset Resilience Insights

Very High Liquidity: Kunming Longjin Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 39.53% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Kunming Longjin Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Kunming Longjin Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Kunming Longjin Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Kunming Longjin Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	5.82%	CN¥33.42 Million ≈ $4.89 Million	CN¥574.40 Million ≈ $84.05 Million	-13.72pp
2023-12-31	19.54%	CN¥123.41 Million ≈ $18.06 Million	CN¥631.63 Million ≈ $92.43 Million	-9.00pp
2022-12-31	28.54%	CN¥213.27 Million ≈ $31.21 Million	CN¥747.21 Million ≈ $109.34 Million	-11.04pp
2021-12-31	39.58%	CN¥327.45 Million ≈ $47.92 Million	CN¥827.28 Million ≈ $121.06 Million	+5.41pp
2020-12-31	34.17%	CN¥287.61 Million ≈ $42.09 Million	CN¥841.76 Million ≈ $123.18 Million	+8.35pp
2019-12-31	25.82%	CN¥208.30 Million ≈ $30.48 Million	CN¥806.89 Million ≈ $118.07 Million	+26.07pp
2018-12-31	-0.25%	CN¥-1.98 Million ≈ $-289.05K	CN¥787.55 Million ≈ $115.24 Million	+0.15pp
2017-12-31	-0.40%	CN¥-3.11 Million ≈ $-455.41K	CN¥785.23 Million ≈ $114.90 Million	-0.16pp
2016-12-31	-0.24%	CN¥-1.79 Million ≈ $-262.65K	CN¥759.68 Million ≈ $111.17 Million	-24.56pp
2015-12-31	24.33%	CN¥170.00 Million ≈ $24.88 Million	CN¥698.86 Million ≈ $102.27 Million	+24.36pp
2011-12-31	-0.03%	CN¥-91.00K ≈ $-13.32K	CN¥287.36 Million ≈ $42.05 Million	--

pp = percentage points

About Kunming Longjin Pharmaceutical Co Ltd

SHE:002750 China Drug Manufacturers - Specialty & Generic

Market Cap

$34.58 Million

CN¥236.29 Million CNY

Market Cap Rank

#23369 Global

#4713 in China

Share Price

CN¥0.59

Change (1 day)

+0.00%

52-Week Range

CN¥0.59 - CN¥0.59

All Time High

CN¥25.99